Related references
Note: Only part of the references are listed.Chest CT Diagnosis and Clinical Management of Drug-Related Pneumonitis in Patients Receiving Molecular Targeting Agents and Immune Checkpoint Inhibitors A Position Paper From the Fleischner Society
Takeshi Johkoh et al.
CHEST (2021)
Analysis of study drug-related interstitial lung disease (ILD) in patients (pts) with HER2+metastatic breast cancer (mBC) treated with trastuzumab deruxtecan (T-DXd)
C. A. Powell et al.
ANNALS OF ONCOLOGY (2021)
Risk of pneumonitis in cancer patients treated with PARP inhibitors: A meta-analysis of randomized controlled trials and a pharmacovigilance study of the FAERS database
Zhuo Ma et al.
GYNECOLOGIC ONCOLOGY (2021)
Interstitial Lung Disease Induced by Anti-ERBB2 Antibody-Drug Conjugates A Review
Paolo Tarantino et al.
JAMA ONCOLOGY (2021)
Olaparib tablets as maintenance therapy in patients with platinum-sensitive relapsed ovarian cancer and a BRCA1/2 mutation (SOLO2/ENGOT-Ov21): a final analysis of a double-blind, randomised, placebo-controlled, phase 3 trial
Andres Poveda et al.
LANCET ONCOLOGY (2021)
Trastuzumab deruxtecan (DS-8201) in patients with HER2-expressing metastatic colorectal cancer (DESTINY-CRC01): a multicentre, open-label, phase 2 trial
Salvatore Siena et al.
LANCET ONCOLOGY (2021)
Cyclin-dependent kinase 4/6 inhibitors and interstitial lung disease in the FDA adverse event reporting system: a pharmacovigilance assessment
Emanuel Raschi et al.
BREAST CANCER RESEARCH AND TREATMENT (2021)
Trastuzumab Deruxtecan in Previously Treated HER2-Positive Breast Cancer
Shanu Modi et al.
NEW ENGLAND JOURNAL OF MEDICINE (2020)
Association of Steroids Use with Survival in Patients Treated with Immune Checkpoint Inhibitors: A Systematic Review and Meta-Analysis
Fausto Petrelli et al.
CANCERS (2020)
COVID-19 pneumonia: CT findings of 122 patients and differentiation from influenza pneumonia
Mengqi Liu et al.
EUROPEAN RADIOLOGY (2020)
Comparison of broad-range polymerase chain reaction and metagenomic next-generation sequencing for the diagnosis of prosthetic joint infection
Chao-xin Wang et al.
INTERNATIONAL JOURNAL OF INFECTIOUS DISEASES (2020)
Interstitial lung abnormalities detected incidentally on CT: a Position Paper from the Fleischner Society
Hiroto Hatabu et al.
LANCET RESPIRATORY MEDICINE (2020)
Risk factors for interstitial lung disease in patients treated with trastuzumab deruxtecan from two interventional studies
C. A. Powell et al.
ANNALS OF ONCOLOGY (2020)
Interstitial pneumonitis related to trastuzumab deruxtecan, a human epidermal growth factor receptor 2-targeting Ab-drug conjugate, in monkeys
Kazuyoshi Kumagai et al.
CANCER SCIENCE (2020)
Coronavirus disease 2019 (COVID-19) in Italy: features on chest computed tomography using a structured report system
Grassi Roberto et al.
SCIENTIFIC REPORTS (2020)
Diagnosis and Treatment of Adults with Community-acquired Pneumonia An Official Clinical Practice Guideline of the American Thoracic Society and Infectious Diseases Society of America
Joshua P. Metlay et al.
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE (2019)
Imaging Patterns Are Associated with Interstitial Lung Abnormality Progression and Mortality
Rachel K. Putman et al.
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE (2019)
The Spectrum of Drug-Induced Interstitial Lung Disease
Ankush Ratwani et al.
CURRENT PULMONOLOGY REPORTS (2019)
Rapid diagnosis of sepsis with TaqMan-Based multiplex real-time PCR
Chang-Feng Liu et al.
JOURNAL OF CLINICAL LABORATORY ANALYSIS (2018)
Management of Immune-Related Adverse Events in Patients Treated With Immune Checkpoint Inhibitor Therapy: American Society of Clinical Oncology Clinical Practice Guideline
Julie R. Brahmer et al.
JOURNAL OF CLINICAL ONCOLOGY (2018)
Diagnosis of Idiopathic Pulmonary Fibrosis An Official ATS/ERS/JRS/ALAT Clinical Practice Guideline
Ganesh Raghu et al.
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE (2018)
Immune-checkpoint inhibitors associated with interstitial lung disease in cancer patients
Myriam Delaunay et al.
EUROPEAN RESPIRATORY JOURNAL (2017)
The Role of Infection in Interstitial Lung Diseases A Review
Natalya Azadeh et al.
CHEST (2017)
Management of toxicities from immunotherapy: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up
J. B. A. G. Haanen et al.
ANNALS OF ONCOLOGY (2017)
PD-1 Inhibitor-Related Pneumonitis in Advanced Cancer Patients: Radiographic Patterns and Clinical Course
Mizuki Nishino et al.
CLINICAL CANCER RESEARCH (2016)
New developments for antibody-drug conjugate-based therapeutic approaches
Bart E. C. G. de Goeij et al.
CURRENT OPINION IN IMMUNOLOGY (2016)
Imaging of Acute Lung Injury
Brett M. Elicker et al.
RADIOLOGIC CLINICS OF NORTH AMERICA (2016)
Chest CT for suspected pulmonary complications of oncologic therapies: how I review and report
Stefan Diederich
CANCER IMAGING (2016)
Severe pneumonitis after nivolumab treatment in a patient with melanoma
Satoshi Watanabe et al.
ALLERGOLOGY INTERNATIONAL (2016)
Antibody Drug Conjugates for Cancer Therapy
Paul Polakis
PHARMACOLOGICAL REVIEWS (2016)
Toxicities of the anti-PD-1 and anti-PD-L1 immune checkpoint antibodies
J. Naidoo et al.
ANNALS OF ONCOLOGY (2015)
American Thoracic Society-European Respiratory Society Classification of the Idiopathic Interstitial Pneumonias: Advances in Knowledge since 2002
Nicola Sverzellati et al.
RADIOGRAPHICS (2015)
Management of BRAF and MEK inhibitor toxicities in patients with metastatic melanoma
Sarah J. Welsh et al.
THERAPEUTIC ADVANCES IN MEDICAL ONCOLOGY (2015)
Update on Procalcitonin Measurements
Michael Meisner
ANNALS OF LABORATORY MEDICINE (2014)
An Official American Thoracic Society/European Respiratory Society Statement: Update of the International Multidisciplinary Classification of the Idiopathic Interstitial Pneumonias
William D. Travis et al.
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE (2013)
Chlamydophila pneumoniae serology: cross-reaction with Mycoplasma pneumoniae infection
Naoyuki Miyashita et al.
JOURNAL OF INFECTION AND CHEMOTHERAPY (2013)
Outcome and predictors of mortality in patients requiring invasive mechanical ventilation due to acute respiratory failure while undergoing ambulatory chemotherapy for solid cancers
So Young Park et al.
SUPPORTIVE CARE IN CANCER (2013)
Consensus statement for the diagnosis and treatment of drug-induced lung injuries
Keishi Kubo et al.
RESPIRATORY INVESTIGATION (2013)
Drug-induced interstitial lung disease: mechanisms and best diagnostic approaches
Osamu Matsuno
RESPIRATORY RESEARCH (2012)
Relative versus absolute change in forced vital capacity in idiopathic pulmonary fibrosis
Luca Richeldi et al.
THORAX (2012)
Forced Vital Capacity in Patients with Idiopathic Pulmonary Fibrosis Test Properties and Minimal Clinically Important Difference
Roland M. du Bois et al.
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE (2011)
Fleischner Society: Glossary of terms tor thoracic imaging
David M. Hansell et al.
RADIOLOGY (2008)
Significance of pulmonary arterial pressure and diffusion capacity of the lung as prognosticator in patients with idiopathic pulmonary fibrosis
Kunio Hamada et al.
CHEST (2007)
Early intervention can improve clinical outcome of acute interstitial pneumonia
GY Suh et al.
CHEST (2006)
ARDS and Diffuse Alveolar Damage: A Pathologist's Perspective
Claudia Y. Castro
SEMINARS IN THORACIC AND CARDIOVASCULAR SURGERY (2006)
Circulating KL-6 levels in patients with drug induced pneumonitis
H Ohnishi et al.
THORAX (2003)
Reversed halo sign on high-resolution CT of cryptogenic organizing pneumonia: Diagnostic implications
SJ Kim et al.
AMERICAN JOURNAL OF ROENTGENOLOGY (2003)
Share Paper
